| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 23, 2002
From the University of Pennsylvania Medical Center, Philadelphia, Pa (M.G.S.J.S., T.P., E.L., D.Z.K.); the University of Kentucky College of Medicine, Lexington, Ky (W.T.A., W.G.F.); Emory University/Crawford Long Hospital, Atlanta, Ga (A.L.S., D.B.D., A.R.L.); Long Beach Memorial Medical Center, Long Beach, Calif (M.E., J.M.); and Medtronic, Inc, Minneapolis, Minn (K.K., K.E.H., M.R.S.H.). * To whom correspondence should be addressed. E-mail: suttonm{at}mail.med.upenn.edu.
Background--Cardiac resynchronization therapy (CRT) has recently emerged as an effective treatment for patients with moderate to severe systolic heart failure and ventricular dyssynchrony. The purpose of the present study was to determine whether improvements in left ventricular (LV) size and function were associated with CRT. Methods and Results--Doppler echocardiograms were obtained at baseline and at 3 and 6 months after therapy in 323 patients enrolled in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) trial. Of these, 172 patients were randomized to CRT on and 151 patients to CRT off. Measurements were made of LV end-diastolic and end-systolic volumes, ejection fraction, LV mass, severity of mitral regurgitation (MR), peak transmitral velocities during early (E-wave) and late (A-wave) diastolic filling, and the myocardial performance index. At 6 months, CRT was associated with reduced end-diastolic and end-systolic volumes (both P<0.001), reduced LV mass (P<0.01), increased ejection fraction (P<0.001), reduced MR (P<0.001), and improved myocardial performance index (P<0.001) compared with control. Conclusions--CRT in patients with moderate-to-severe heart failure who were treated with optimal medical therapy is associated with reverse LV remodeling, improved systolic and diastolic function, and decreased MR. LV remodeling likely contributes to the symptomatic benefits of CRT and may herald improved longer-term survival.
Accepted on February 7, 2003
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure
Martin G. St John Sutton MD*,
-Blocker treatment status did not influence the effect of CRT. Improvements with CRT were greater in patients with a nonischemic versus ischemic cause of heart failure.
This article has been cited by other articles:
![]() |
C. Daubert, M. R. Gold, W. T. Abraham, S. Ghio, C. Hassager, G. Goode, T. Szili-Torok, C. Linde, and on behalf of the REVERSE Study Group Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1837 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Exner Is it Time to Expand the Use of Cardiac Resynchronization Therapy to Patients With Mildly Symptomatic Heart Failure? J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1847 - 1849. [Full Text] [PDF] |
||||
![]() |
M. St. John Sutton, S. Ghio, T. Plappert, L. Tavazzi, L. Scelsi, C. Daubert, W. T. Abraham, M. R. Gold, C. Hassager, J. M. Herre, et al. Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure Circulation, November 10, 2009; 120(19): 1858 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Solis, D. McCarty, R. A. Levine, M. D. Handschumacher, L. Fernandez-Friera, A. Chen-Tournoux, L. Mont, B. Vidal, J. P. Singh, J. Brugada, et al. Mechanism of Decrease in Mitral Regurgitation After Cardiac Resynchronization Therapy: Optimization of the Force-Balance Relationship Circ Cardiovasc Imaging, November 1, 2009; 2(6): 444 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Z. Khan, M. S. Virdee, D. Gopalan, J. Rudd, T. Watson, S. P. Fynn, and D. P. Dutka Characterization of the suitability of coronary venous anatomy for targeting left ventricular lead placement in patients undergoing cardiac resynchronization therapy Europace, November 1, 2009; 11(11): 1491 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Daubert, C. Leclercq, and P. Mabo Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator Europace, November 1, 2009; 11(suppl_5): v87 - v92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.X. Foley, F. Leyva, and M. P. Frenneaux What is treatment success in cardiac resynchronization therapy? Europace, November 1, 2009; 11(suppl_5): v58 - v65. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W.K. Peng, S. Lilley, B. Knight, J. Sinclair, F. Lyall, K. MacArthur, J. C.S. Pollock, and M. H.D. Danton Synergistic interaction between right ventricular mechanical dyssynchrony and pulmonary regurgitation determines early outcome following tetralogy of Fallot repair Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 694 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Kwon, C. M. Halley, Z. B. Popovic, T. P. Carrigan, V. Zysek, R. Setser, P. Schoenhagen, S. D. Flamm, R. C. Starling, and M. Y. Desai Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance Eur J Heart Fail, October 1, 2009; 11(10): 937 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Patwala, P. R. Woods, L. Sharp, D. F. Goldspink, L. B. Tan, and D. J. Wright Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training: A Randomized Controlled Study J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2332 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Hawkins, M. C. Petrie, M. I. Burgess, and J. J.V. McMurray Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1944 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boveda, E. Marijon, S. Jacob, P. Defaye, J. B. Winter, A. Bulava, D. Gras, J. P. Albenque, N. Combes, D. Pavin, et al. Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study Eur. Heart J., May 2, 2009; 30(10): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghio, N. Freemantle, L. Scelsi, A. Serio, G. Magrini, M. Pasotti, A. Shankar, J. G.F. Cleland, and L. Tavazzi Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial Eur J Heart Fail, May 1, 2009; 11(5): 480 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Z. Khan, M. S. Virdee, S. P. Fynn, and D. P. Dutka Left ventricular lead placement in cardiac resynchronization therapy: where and how? Europace, May 1, 2009; 11(5): 554 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-U. Voigt, T.-M. Schneider, S. Korder, M. Szulik, E. Gurel, W. G. Daniel, F. Rademakers, and F. A. Flachskampf Apical transverse motion as surrogate parameter to determine regional left ventricular function inhomogeneities: a new, integrative approach to left ventricular asynchrony assessment Eur. Heart J., April 2, 2009; 30(8): 959 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.X. Foley, S. A. Muhyaldeen, S. Chalil, R. E.A. Smith, J. E. Sanderson, and F. Leyva Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure Europace, April 1, 2009; 11(4): 495 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chakir, S. K. Daya, T. Aiba, R. S. Tunin, V. L. Dimaano, T. P. Abraham, K. Jaques, E. W. Lai, K. Pacak, W.-Z. Zhu, et al. Mechanisms of Enhanced {beta}-Adrenergic Reserve From Cardiac Resynchronization Therapy Circulation, March 10, 2009; 119(9): 1231 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mullens, R. A. Grimm, T. Verga, T. Dresing, R. C. Starling, B. L. Wilkoff, and W.H. W. Tang Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J. Am. Coll. Cardiol., March 3, 2009; 53(9): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mullens, T. Verga, R. A. Grimm, R. C. Starling, B. L. Wilkoff, and W.H. W. Tang Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J. Am. Coll. Cardiol., February 17, 2009; 53(7): 600 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q Zhang, J W-H Fung, J Y-S Chan, G Yip, Y-Y Lam, Y-J Liang, and C-M Yu Difference in long-term clinical outcome after cardiac resynchronisation therapy between ischaemic and non-ischaemic aetiologies of heart failure Heart, January 15, 2009; 95(2): 113 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Kwon, C. M. Halley, T. P. Carrigan, V. Zysek, Z. B. Popovic, R. Setser, P. Schoenhagen, R. C. Starling, S. D. Flamm, and M. Y. Desai Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 34 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nazeri, A. Massumi, A. Rasekh, M. Saeed, C. Frank, J. M. Wilson, J. A. Lopez, and M. Razavi Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony Europace, January 1, 2009; 11(1): 86 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sredniawa, R. Lenarczyk, O. Kowalski, P. Pruszkowska-Skrzep, J. Kowalczyk, A. Musialik-Lydka, S. Cebula, and Z. Kalarus Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy Europace, January 1, 2009; 11(1): 106 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper CHAPTER 21 Valvular Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leclercq, P. Mabo, and J. N. Trochu Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far? J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1844 - 1846. [Full Text] [PDF] |
||||
![]() |
C. Linde, W. T. Abraham, M. R. Gold, M. St. John Sutton, S. Ghio, C. Daubert, and REVERSE (REsynchronization reVErses Remodeling in Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1834 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Z Naqvi, A M Rafique, C Swerdlow, S Verma, R J Siegel, K Tolstrup, W Kerwin, J Goodman, D Gallik, E Gang, et al. Predictors of reduction in mitral regurgitation in patients undergoing cardiac resynchronisation treatment Heart, December 1, 2008; 94(12): 1580 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bildirici, A. Vural, A. Agacdiken, T. Sahin, U. Celikyurt, T. Kilic, and D. Ural Comparison of the effects of left vs. right ventricular pacing on left ventricular remodelling Europace, December 1, 2008; 10(12): 1387 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ypenburg, R. J. van Bommel, V. Delgado, S. A. Mollema, G. B. Bleeker, E. Boersma, M. J. Schalij, and J. J. Bax Optimal Left Ventricular Lead Position Predicts Reverse Remodeling and Survival After Cardiac Resynchronization Therapy J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1402 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
L. Di Biase, A. Auricchio, A. Sorgente, K. Civello, C. Klersy, F. Faletra, L. Riedlbauchova, D. Patel, M. Arruda, R. A. Schweikert, et al. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy Eur. Heart J., October 2, 2008; 29(20): 2497 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stanton, N. M. Hawkins, K. J. Hogg, N. E.R. Goodfield, M. C. Petrie, and J. J.V. McMurray How should we optimize cardiac resynchronization therapy? Eur. Heart J., October 2, 2008; 29(20): 2458 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
B. Kirn, A. Jansen, F. Bracke, B. van Gelder, T. Arts, and F. W. Prinzen Mechanical discoordination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H640 - H646. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Carabello The Current Therapy for Mitral Regurgitation J. Am. Coll. Cardiol., July 29, 2008; 52(5): 319 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Prinzen and A. Auricchio Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy?: Echocardiography Is Not Useful Before Cardiac Resynchronization Therapy if QRS Duration Is Available Circ Cardiovasc Imaging, July 1, 2008; 1(1): 70 - 78. [Full Text] [PDF] |
||||
![]() |
K Khadjooi, P W Foley, S Chalil, J Anthony, R E A Smith, M P Frenneaux, and F Leyva Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation Heart, July 1, 2008; 94(7): 879 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.M. Jansen, F. Bracke, J. m. van Dantzig, K. H. Peels, J. C. Post, H. C.M. van den Bosch, B. van Gelder, A. Meijer, H. H.M. Korsten, J. de Vries, et al. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy Eur J Echocardiogr, July 1, 2008; 9(4): 483 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Sweeney and F. W. Prinzen Ventricular Pump Function and Pacing: Physiological and Clinical Integration Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 127 - 139. [Full Text] [PDF] |
||||
![]() |
D. P.S. Rogers, S. Marazia, A. W. Chow, P. D. Lambiase, M. D. Lowe, M. Frenneaux, W. J. McKenna, and P. M. Elliott Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy Eur J Heart Fail, May 1, 2008; 10(5): 507 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leclercq, F. Gadler, W. Kranig, S. Ellery, D. Gras, A. Lazarus, J. Clementy, E. Boulogne, J.-C. Daubert, and for the TRIP-HF (Triple Resynchronization In Paced A Randomized Comparison of Triple-Site Versus Dual-Site Ventricular Stimulation in Patients With Congestive Heart Failure J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1455 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Borggrefe, T. Lawo, C. Butter, H. Schmidinger, M. Lunati, B. Pieske, A. R. Misier, A. Curnis, D. Bocker, A. Remppis, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure Eur. Heart J., April 2, 2008; 29(8): 1019 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ypenburg, P. Lancellotti, L. F. Tops, E. Boersma, G. B. Bleeker, E. R. Holman, J. D. Thomas, M. J. Schalij, L. A. Pierard, and J. J. Bax Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy Eur. Heart J., March 2, 2008; 29(6): 757 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Milliez, O. Thomas, A. Haggui, P. Schurando, P. Squara, A. Cohen-Solal, A. Mebazaa, and A. Leenhardt Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: Results from a short and mid-term study Eur J Heart Fail, March 1, 2008; 10(3): 291 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inage, T. Yoshida, T. Hiraki, M. Ohe, T. Takeuchi, Y. Nagamoto, Y. Fukuda, T. Gondo, and T. Imaizumi Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment Europace, March 1, 2008; 10(3): 379 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow Evolving Concepts and Technologies in Mitral Valve Repair Circulation, February 19, 2008; 117(7): 963 - 974. [Full Text] [PDF] |
||||
![]() |
S. F. Nagueh Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 18 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
T V Salukhe, K Dimopoulos, R Sutton, P Poole-Wilson, M Y Henein, M Morgan, J R Clague, and D P Francis Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic time Heart, January 1, 2008; 94(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ypenburg, P. Lancellotti, L. F. Tops, G. B. Bleeker, E. R. Holman, L. A. Pierard, M. J. Schalij, and J. J. Bax Acute Effects of Initiation and Withdrawal of Cardiac Resynchronization Therapy on Papillary Muscle Dyssynchrony and Mitral Regurgitation J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2071 - 2077. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B Bleeker, C.-M. Yu, P. Nihoyannopoulos, J. de Sutter, N. Van de Veire, E. R Holman, M. J Schalij, E. E van der Wall, and J. J Bax Optimal use of echocardiography in cardiac resynchronisation therapy Heart, November 1, 2007; 93(11): 1339 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Uebing, D. G. Gibson, S. V. Babu-Narayan, G. P. Diller, K. Dimopoulos, O. Goktekin, M. S. Spence, K. Andersen, M. Y. Henein, M. A. Gatzoulis, et al. Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot: Implications of Infundibular Disease Circulation, October 2, 2007; 116(14): 1532 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mann, M. A. Acker, M. Jessup, H. N. Sabbah, R. C. Starling, and S. H. Kubo Clinical Evaluation of the CorCap Cardiac Support Device in Patients With Dilated Cardiomyopathy Ann. Thorac. Surg., October 1, 2007; 84(4): 1226 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H.M. Hessel, G. B. Bleeker, J. J. Bax, M. M. Henneman, B. den Adel, M. Klok, M.J. Schalij, D. E. Atsma, and A. van der Laarse Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels Eur J Heart Fail, October 1, 2007; 9(10): 1058 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF] |
||||
![]() |
D. A. Kass Highlighting the R in CRT Circulation, September 25, 2007; 116(13): 1434 - 1436. [Full Text] [PDF] |
||||
![]() |
G. B. Bleeker, S. A. Mollema, E. R. Holman, N. Van De Veire, C. Ypenburg, E. Boersma, E. E. van der Wall, M. J. Schalij, and J. J. Bax Left Ventricular Resynchronization Is Mandatory for Response to Cardiac Resynchronization Therapy: Analysis in Patients With Echocardiographic Evidence of Left Ventricular Dyssynchrony at Baseline Circulation, September 25, 2007; 116(13): 1440 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF] |
||||
![]() |
K. Vernooy, R. N.M. Cornelussen, X. A.A.M. Verbeek, W. Y.R. Vanagt, A. van Hunnik, M. Kuiper, T. Arts, H. J.G.M. Crijns, and F. W. Prinzen Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts Eur. Heart J., September 1, 2007; 28(17): 2148 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Yu, F. Fang, Q. Zhang, G. W.K. Yip, C. M. Li, J. Y.-S. Chan, L. Wu, and J. W.-H. Fung Improvement of Atrial Function and Atrial Reverse Remodeling After Cardiac Resynchronization Therapy for Heart Failure J. Am. Coll. Cardiol., August 21, 2007; 50(8): 778 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Fruhwald, A. Fahrleitner-Pammer, R. Berger, F. Leyva, N. Freemantle, E. Erdmann, D. Gras, L. Kappenberger, L. Tavazzi, J.-C. Daubert, et al. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony Eur. Heart J., July 1, 2007; 28(13): 1592 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Haykowsky, Y. Liang, D. Pechter, L. W. Jones, F. A. McAlister, and A. M. Clark A Meta-Analysis of the Effect of Exercise Training on Left Ventricular Remodeling in Heart Failure Patients: The Benefit Depends on the Type of Training Performed J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2329 - 2336. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Valzania, F. Gadler, M. J. Eriksson, A. Olsson, G. Boriani, and F. Braunschweig Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure Eur J Heart Fail, June 1, 2007; 9(6-7): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Burkhardt and B. L. Wilkoff Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure Circulation, April 24, 2007; 115(16): 2208 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Rao, U. N. Kumar, J. Schafer, E. Viloria, D. De Lurgio, and E. Foster Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing Circulation, April 24, 2007; 115(16): 2136 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lichodziejewska, K. Kurnicka, K. Grudzka, J. Malysz, M. Ciurzynski, and D. Liszewska-Pfejfer Chronic and Acute Effects of Smoking on Left and Right Ventricular Relaxation in Young Healthy Smokers Chest, April 1, 2007; 131(4): 1142 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Hauptman and H. N. Sabbah Reversal of ventricular remodeling: Important to establish and difficult to define Eur J Heart Fail, April 1, 2007; 9(4): 325 - 328. [Full Text] [PDF] |
||||
![]() |
M. Kubanek, I. Malek, J. Bytesnik, P. Fridl, L. Riedlbauchova, L. Karasova, V. Lanska, and J. Kautzner Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months Eur J Heart Fail, December 1, 2006; 8(8): 832 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bristow Cardiac resynchronization therapy and adrenergic mechanisms Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2590 - H2591. [Full Text] [PDF] |
||||
![]() |
G. B. Bleeker, E. R. Holman, P. Steendijk, E. Boersma, E. E. van der Wall, M. J. Schalij, and J. J. Bax Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex J. Am. Coll. Cardiol., November 8, 2006; (2006) j.jacc.2006.07.067v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rivero-Ayerza, D. A.M.J. Theuns, H. M. Garcia-Garcia, E. Boersma, M. Simoons, and L. J. Jordaens Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials Eur. Heart J., November 2, 2006; 27(22): 2682 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Thompson, G. Saab, D. Birnie, B. J.W. Chow, H. Ukkonen, K. Ananthasubramaniam, R. A. deKemp, L. Garrard, T. D. Ruddy, J. N. DaSilva, et al. Is Septal Glucose Metabolism Altered in Patients with Left Bundle Branch Block and Ischemic Cardiomyopathy? J. Nucl. Med., November 1, 2006; 47(11): 1763 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cicoira, D. Natarajan, C. A. Henrikson, and J. Jarcho Biventricular Pacing N. Engl. J. Med., October 19, 2006; 355(16): 1738 - 1739. [Full Text] [PDF] |
||||
![]() |
M. Toyama, A. Usui, T. Abe, H. Oshima, T. Akita, and Y. Ueda Mitral Valve Surgery for Dilated Cardiomyopathy with Mitral Regurgitation Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 371 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rubaj, P. Rucinski, K. Rejdak, K. Oleszczak, D. Duma, P. Grieb, and A. Kutarski Biventricular versus right ventricular pacing decreases immune activation and augments nitric oxide production in patients with chronic heart failure Eur J Heart Fail, October 1, 2006; 8(6): 615 - 620. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |